additive genetic factors, seeds became far more numerous, larger, and heavier. The increasing 1 0 0 pressure on plant stalks required new mutations that enabled plants to remain erect under the 1 0 1 increased seed weight --this epistatic interaction enabled the Green Revolution [28] that 1 0 2 vastly increased food security in many poor parts of the world [29] . In humans, twin concordance rates indicate that at least some of the genetic variation 1 0 4 influencing complex diseases is non-additive. Experimental evidence demonstrates that 1 0 5 epistasis, i.e. the phenotypically relevant, and often non-reciprocal interaction of non-allelic 1 0 6 genes, is pervasive in complex traits in various model organisms [30] [31] [32] . There is no reason 1 0 7 to assume that the genetic architecture of complex traits differs between humans and other 1 0 8 highly complex eukaryotes. Therefore, the inclusion of epistatic effects in statistical models 1 0 9 has been increasingly suggested and even attempted in some studies [27, 33, 34] . Although 1 1 0 models that allow for all gene × gene (and gene × gene × gene, etc) interactions will be more 1 1 1 realistic, such a higher-order models require much larger datasets and faster algorithms 1 1 2 [33, [35] [36] [37] [38] [39] . Studies in model organisms suggest that a simpler, two-state epistasis may apply to 1 1 4 complex traits and diseases [32, 40] . In contrast to the familiar often small-effect, gene x gene 1 1 5 interactions, certain genetic and environmental factors can act as strong modifiers for many 1 1 6 other loci [30, [41] [42] [43] [44] [45] [46] . In addition, the activity of strong genetic modifiers can be modulated 1 1 7 by environmental stress [47] . Based on studies in plants, worms, and yeast, the number of 1 1 8 strong genetic modifiers is small, possibly ~10% of all genes [30, 46, 48] . Although the existence of differences in variant penetrance among individuals is not a 1 2 0 new concept, its effect on GWAS in humans has not been investigated. Here, we present a 1 2 1 simple two-state epistasis model, in which binary disease status of an individual depends on a 1 2 2 combination of additive alleles (as before) as well as their penetrance in a given individual. consisting of all individuals with increased penetrance of many different genetic variants will 1 2 5 7 have higher phenotypic variation, i.e. it will be less phenotypically robust, than an otherwise 1 2 6 equivalent population consisting of all robust individuals with low penetrance [31] . Theoretical population genetics provides a strong argument for the potential benefits of show, this model increases the power to detect additive trait-associated loci and improves fits 1 3 0 with heritability observations based on twin studies. Although it is perhaps unsurprising that 1 3 1 adding a parameter to a model improves its predictive power, that is precisely our point --1 3 2 only one parameter, not g 2 , g 3 ,... interaction parameters (where g is the number of genes in the 1 3 3 genome), results in a marked improvement of fit. In the absence of robustness measures in humans, one may argue that such model is of 1 3 5 limited use to improve GWAS in humans. However, we argue that our model's success 1 3 6 should inform our approach to finding disease-causing loci and we discuss strategies how to 1 3 7 apply it to existing and future GWAS data. -doubling the slope of the line of regression between parent-offspring pairs -results in a 1 5 0 substantially smaller estimate of the additive heritability ( Fig. 1A, inset) .
The degree to which this observable discrete additive heritability (h 2 o ) is decreased simplifying assumption that the quantitative trait (liability) is normally distributed in the Expected values for h 2 bin can also be determined via simulation, in which the additive for these traits -O(h 2 bin ) -are much higher (Table S1) , calling a purely additive model into
To explore the implied non-additive factors, we developed a simulator that designates 1 7 2 a subset of the population as non-robust by incorporating a robustness perturbation factor that binary trait is at very low frequency ( Fig. 1B, yellow curve) . Below, we explore the effect of 1 7 9
varying this robustness factor, as well as the frequency of non-robust individuals in the 1 8 0 population and the contribution of non-genetic factors (H 2 <1). that are a mixture of robust and non-robust individuals produce levels of h 2 bin that are more 1 9 6 consistent with empirically determined O(h 2 bin ) from twin studies (Fig. 1C , Table S1 ). each individual in a population has a positive liability that is simply a linear combination of n 2 0 0 additive genetic factors and noise (ε) ( Fig. 2A) . Individuals with liability in the top fraction of We then generated mixed populations in which some fraction of the population is First, we assigned a novel liability factor of large additive effect to our non-robust individuals 2 0 7
( Fig 2B) . Second, we increased the fraction of liability due to noise (Fig 2C) . Third, we 2 0 8
increased the effect size of additive alleles contributing to liability by a factor of c α (Fig 2D) . Fourth, we assumed that lack of robustness revealed c n additional additive alleles (Fig 2E) . We implemented these models in our simulator (see Fig. 3 and Supplementary 2 1 5
Methods for details). Our aim was to measure the effect of changing certain parameter values, increases. This is true for both the non-robust subpopulation and the entire population, which 2 2 3
is why we use a percentile (φ) rather than an absolute threshold to determine 2 2 4 affected/unaffected status. several complex diseases (Fig. 1C, Table S1 ). This is due to the fact that as c α or c n increase 2 3 1 and remains constant, the fraction of liability that is determined by genetics (H 2 ) increases 2 3 2 for the non-robust subpopulation and, by extension, for the entire population. is modeled as hiding cryptic variation or reducing penetrance of variants, if the goal is to find 2 3 6 additive risk-loci (i.e. which may be good therapeutic targets), it is best to use only robust 2 3 7 individuals for both affected and unaffected groups (Fig. 4B) . Of course, controlling for a 2 3 8 hidden robustness state, which modifies the effect of many alleles, returns the experiment to the situation for which GWAS was designed --a purely additive model. It is less intuitive why 2 4 0 using only robust (rather than all non-robust) individuals improves our ability to detect 2 4 1 additive risk alleles in GWAS, which is a result we explore below. alleles than non-robust affected individuals. Here we assume that non-robust and robust 2 4 7 individuals carry the same additive alleles.
4 8
In the case of increased penetrance, the explanation is similar to that given for why 2 4 9 common risk alleles are more easily found than rare alleles that increase risk by the same presence of the multitude of other lesser risk-associated loci much more readily than model B. We conclude that (i) a model that includes a house-of-cards robustness state explains 2 8 4 the observed data for several complex diseases better than one without, (ii) when looking for 2 8 5 loci with additive risk alleles it is best to use all robust individuals for both cases and controls, and (iii) 'robustness' loci are unlikely to be identified in GWAS.
8 7
In any given family, a faulty 'robustness' allele passed on from parent to child will act as a among relatives and missing heritability in GWAS.
9 0
An obvious challenge is how to identify robust and non-robust humans. There are 2 9 1 multiple plausible approaches that haven't been fully explored. In humans, one may identify 'robustness' genes by comparing individuals with high 2 9 3 comorbidity of complex diseases to those with none; however, to our knowledge, this has yet to 2 9 4 be done. Another currently available approach would be to pool individuals that are affected by 2 9 5 distinct complex diseases and compare these to their pooled unaffected controls. As we expect 2 9 6 non-robust individuals to be overrepresented among affected individuals for any complex 2 9 7
disease, this GWAS approach may identify 'robustness' loci because the frequency of perturbed 'robustness' loci is increased. Indeed, this approach has shown promise for neurological A third approach possible with current data would be to assume that the GWAS loci no obvious association between gene function and a specific disease --and proceed by 3 0 8
controlling for these additive risk allele, recalling that statistical additivity is often an 3 0 9 emergent property of underlying epistatic interactions [26, 32, 66] .
Even without knowing the etiology of robustness status, it may be possible separate to genetics should be greater in increasingly heterozygous populations. higher mutation penetrance [79, 80] . Non-robust individuals may also be identified as outliers environmental risk-factor should be readily identified through epidemiological studies, there 3 3 0 could be a time lag between the environmental insult and the disease or a house-of-cards 3 3 1 mechanism for multiple environmental insults that make them difficult to pinpoint. Finally, it should be noted that compared to the vast resources committed to GWAS, 3 3 3 exploring these potential markers in model organism studies seems worthwhile. the effect size of any one such 'robustness' gene to levels comparable to that most commonly 4 1 7
found for additive risk alleles in which the risk allele is the minor allele (1 < OR buff < 2, Missing Heritability. PLoS Genet. 9, e1003295. Nature 396, 336-342. 
